Home>

Products

Submit Request Quote
 * Denotes Required Field.
Name:
 *
Company Name:
Phone:
Email:
 *
Message:
Request Quote
 
Out Of Stock image

Is currently out of stock, however if you enter your email address we will notify you when it comes back into stock!

Continue shopping Get Notified

Anti-primate IgG [8F1]-biotin

Anti-primate IgG [8F1]-biotin
Product Type: Reagents for IgG Detection
Format: Anti-primate IgG-biotin, 8F1, mouse variable region, mouse IgG1 Fc
Clone ID: [8F1]
RRID: AB_2819299
Common Names: Anti-primate IgG [8F1]-biotin | Anti-primate IgG (pan-species reactive)-biotin | 8F1-E2-H3-B1 | PR-8616 | CAT-00267
Target: IgG
Reactivity: Human (Homo sapiens) Rhesus Macaque (Macaca mulatta) African Green (Chlorocebus pygerythrus) Cynomolgus Monkey (Macaca fascicularis) Common Marmoset (Callithrix jacchus) Olive Baboon (Papio anubis)
Applications: in vitro; ELISA
Description:

8F1-biotin: Purified mouse monoclonal antibody that reacts with IgG of human, macaque, vervet, mangabey, baboon, and chimpanzee. Conjugated to biotin.
Modifications: biotin
Restrictions: No
Sponsor: NIAID
How to cite (Methods): Anti-primate IgG [8F1]-biotin (NHPRR Cat#PR-8616, RRID:AB_2819299)
How to cite (Acknowledgments): The Anti-primate IgG [8F1]-biotin antibody used in this study was provided by the NIH Nonhuman Primate Reagent Resource (NIAID U24 AI126683).

Reagent cost, which is the actual cost of production, is recovered for some reagents. Please inquire if you have questions about reagent cost recovery. Purchase order or credit card is NOW REQUIRED for cost-recovered reagents.

You are not authorized to purchase this product. Please ensure you are logged into your account.

CAN'T FIND EXACTLY WHAT YOUR RESEARCH REQUIRES?

Request a Reagent:

Would you like to see an NHP-specific antibody developed through the program? Suggest a new reagent that would benefit the NHP community.

REQUEST A REAGENT

The Nonhuman Primate Reagent Resource (NHPRR) is a nonprofit laboratory established in 1999, and supported by the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID), and Office of Research Infrastructure Programs (ORIP).

Copyright © 2004-2025